Presence and extent of cardiac magnetic resonance microvascular obstruction in reperfused Non-ST-elevated myocardial infarction and correlation with infarct size and myocardial enzyme release

Cardiology

Volumn 113, Issue 1, 2009, Pages 50-58

  Mewton, N ^a,b   Bonnefoy, E ^a   Revel, D ^a   Ovize, M ^a   Kirkorian, G ^a   Croisille, P ^a  

^a UNIVERSITÉ DE LYON   (France)

^b NONE   (France)

Author keywords

Acute coronary syndromes; Acute myocardial infarction; Cardiac magnetic resonance; Microvascular obstruction

Indexed keywords

CREATINE KINASE; GADOLINIUM; MITOCHONDRIAL ENZYME; TROPONIN I;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CINEANGIOCARDIOGRAPHY; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CREATINE KINASE BLOOD LEVEL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ENZYME BLOOD LEVEL; ENZYME RELEASE; FEMALE; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HEART MUSCLE REPERFUSION; HUMAN; MALE; NO REFLOW PHENOMENON; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; ST SEGMENT ELEVATION;

ADULT; AGED; AGED, 80 AND OVER; CORONARY ANGIOGRAPHY; CREATINE KINASE; FEMALE; GADOLINIUM; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MICROVESSELS; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIUM; NECROSIS; PROSPECTIVE STUDIES; TROPONIN I; VENTRICULAR FUNCTION, LEFT;

EID: 55149122879     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000167042     Document Type: Article

References (32)

1. Wu KC, Zerhouni EA, Judd RM, LugoOliv ieri CH, Barouch LA, Schulman SP, Blumenthal RS, Lima JA: Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 1998; 97: 765-772.
2. Hamada S, Nishiue T, Nakamura S, Sugiura T, Kamihata H, Miyoshi H, Imuro Y, Iwasaka T: TIMI frame count immediately after primary coronary angioplasty as a predictor of functional recovery in patients with TIMI 3 reperfused acute myocardial infarction. J Am Coll Cardiol 2001; 38: 666-671.
3. Hombach V, Grebe O, Merkle N, Waldenmaier S, Hoher M, Kochs M, Wohrle J, Kestler HA: Sequelae of acute myocardial infarction regarding cardiac structure and function and their prognostic significance as assessed by magnetic resonance imaging. Eur Heart J 2005; 26: 549-557.
4. Ito H, Maruyama A, Iwakura K, Takiuchi S, Masuyama T, Hori M, Higashino Y, Fujii K, Minamino T: Clinical implications of the 'no reflow' phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation 1996; 93: 223-228.
5. Taylor AJ, Al-Saadi N, Abdel-Aty H, Schulz- Menger J, Messroghli DR, Friedrich MG: Detection of acutely impaired microvascular reperfusion after infarct angioplasty with magnetic resonance imaging. Circulation 2004; 109: 2080-2085.
6. Morishima I, Sone T, Okumura K, Tsuboi H, Kondo J, Mukawa H, Matsui H, Toki Y, Ito T, Hayakawa T: Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. J Am Coll Cardiol 2000; 36: 1202-1209.
7. Galiuto L, Lombardo A, Maseri A, Santoro L, Porto I, Cianflone D, Rebuzzi AG, Crea F: Temporal evolution and functional outcome of no reflow: sustained and spontaneously reversible patterns following successful coronary recanalisation. Heart 2003; 89: 731-737.
8. Avezum A, Makdisse M, Spencer F, Gore JM, Fox KA, Montalescot G, Eagle KA, White K, Mehta RH, Knobel E, Collet JP: Impact of age on management and outcome of acute coronary syndrome: observations from the Global Registry of Acute Coronary Events (GRACE). Am Heart J 2005; 149: 67-73.
9. Bertrand ME, Simoons ML, Fox KA, Wallentin LC, Hamm CW, McFadden E, De Feyter PJ, Specchia G, Ruzyllo W: Management of acute coronary syndromes in patients presenting without persistent STsegment elevation. Eur Heart J 2002; 23:1809-1840.
10. Yeghiazarians Y, Braunstein JB, Askari A, Stone PH: Unstable angina pectoris. N Engl J Med 2000; 342: 101-114.
11. Savonitto S, Ardissino D, Granger CB, Morando G, Prando MD, Mafrici A, Cavallini C, Melandri G, Thompson TD, Vahanian A, Ohman EM, Califf RM, Van de Werf F, Topol EJ: Prognostic value of the admission electrocardiogram in acute coronary syndromes. JAMA 1999; 281: 707-713.
12. Antman EM, Cohen M, Bernink PJ, McCabe CH, Horacek T, Papuchis G, Mautner B, Corbalan R, Radley D, Braunwald E: The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA 2000; 284: 835-842.
13. Boersma E, Pieper KS, Steyerberg EW, Wilcox RG, Chang WC, Lee KL, Akkerhuis KM, Harrington RA, Deckers JW, Armstrong PW, Lincoff AM, Califf RM, Topol EJ, Simoons ML: Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9,461 patients. The PURSUIT Investigators. Circulation2000; 101: 2557-2567.
14. Rationale and design of the GRACE (Global Registry of Acute Coronary Events) project: a multinational registry of patients hospitalized with acute coronary syndromes. Am Heart J 2001; 141: 190-199.
15. Chesebro JH, Knatterud G, Roberts R, Borer J, Cohen LS, Dalen J, Dodge HT, Francis CK, Hillis D, Ludbrook P, et al: Thrombolysis in Myocardial Infarction (TIMI) trial, phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation 1987; 76: 142-154.
16. Albert TS, Kim RJ, Judd RM: Assessment of no-reflow regions using cardiac MRI. Basic Res Cardiol 2006; 101: 383-390.
17. Lund GK, Stork A, Saeed M, Bansmann MP, Gerken JH, Muller V, Mester J, Higgins CB, Adam G, Meinertz T: Acute myocardial infarction: evaluation with first-pass enhancement and delayed enhancement MR imaging compared with 201Tl SPECT imaging. Radiology 2004; 232: 49-57.
18. Lima JA, Judd RM, Bazille A, Schulman SP, Atalar E, Zerhouni EA: Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI. Potential mechanisms. Circulation 1995; 92: 1117-1125.
19. Nijveldt R, Beek AM, Hofman MB, Umans VA, Algra PR, Spreeuwenberg MD, Visser CA, van Rossum AC: Late gadolinium-enhanced cardiovascular magnetic resonance evaluation of infarct size and microvascular obstruction in optimally treated patients after acute myocardial infarction. J Cardiovasc Magn Reson 2007; 9: 765-770.
20. Henriques JP, Zijlstra F, van 't Hof AW, de Boer MJ, Dambrink JH, Gosselink M, Hoorntje JC, Suryapranata H: Angiographic assessment of reperfusion in acute myocardial infarction by myocardial blush grade. Circulation 2003; 107: 2115-2119.
21. Sakuma T, Hayashi Y, Sumii K, Imazu M, Yamakido M: Prediction of short- and intermediate- term prognoses of patients with acute myocardial infarction using myocardial contrast echocardiography one day after recanalization. J Am Coll Cardiol 1998; 32: 890-897.
22. Bolognese L, Carrabba N, Parodi G, Santoro GM, Buonamici P, Cerisano G, Antoniucci D: Impact of microvascular dysfunction on left ventricular remodeling and long-term clinical outcome after primary coronary angioplasty for acute myocardial infarction. Circulation 2004; 109: 1121-1126.
23. Rezkalla SH, Kloner RA: No-reflow phenomenon. Circulation 2002; 105: 656-662.
24. Reffelmann T, Kloner RA: The no-reflow phenomenon: a basic mechanism of myocardial ischemia and reperfusion. Basic Res Cardiol 2006; 101: 359-372.
25. Skyschally A, Leineweber K, Gres P, Haude M, Erbel R, Heusch G: Coronary microembolization. Basic Res Cardiol 2006; 101: 373-382.
26. Kloner RA, Ganote CE, Jennings RB: The 'no-reflow' phenomenon after temporary coronary occlusion in the dog. J Clin Invest 1974; 54: 1496-1508.
27. Iwakura K, Ito H, Kawano S, Shintani Y, Yamamoto K, Kato A, Ikushima M, Tanaka K, Kitakaze M, Hori M, Higashino Y, Fujii K: Predictive factors for development of the noreflow phenomenon in patients with reperfused anterior wall acute myocardial infarction. J Am Coll Cardiol 2001; 38: 472-477.
28. Ambrosio G, Weisman HF, Mannisi JA, Becker LC: Progressive impairment of regional myocardial perfusion after initial restoration of postischemic blood flow. Circulation 1989; 80: 1846-1861.
29. Ingkanisorn WP, Rhoads KL, Aletras AH, Kellman P, Arai AE: Gadolinium delayed enhancement cardiovascular magnetic resonance correlates with clinical measures of myocardial infarction. J Am Coll Cardiol 2004; 43: 2253-2259.
30. Choi KM, Kim RJ, Gubernikoff G, Vargas JD, Parker M, Judd RM: Transmural extent of acute myocardial infarction predicts longterm improvement in contractile function. Circulation 2001; 104: 1101-1107.
31. Wu E, Judd RM, Vargas JD, Klocke FJ, Bonow RO, Kim RJ: Visualisation of presence, location, and transmural extent of healed Qwave and non-Q-wave myocardial infarction. Lancet 2001; 357: 21-28.
32. Haase J, Bayar R, Hackenbroch M, Storger H, Hofmann M, Schwarz CE, Reinemer H, Schwarz F, Ruef J, Sommer T: Relationship between size of myocardial infarctions assessed by delayed contrast-enhanced MRI after primary PCI, biochemical markers, and time to intervention. J Interv Cardiol 2004; 17: 367-373.